Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

Digital health company Akili has launched a non-prescription version of its attention-deficit hyperactivity disorder (ADHD) digital therapeutic EndeavorRx, that can be downloaded from the Apple App ...

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and ...

Ubongo, Africa’s leading edutainment organization, is thrilled to announce the launch of Season 5 of its early childhood development program, Akili and Me, featuring a vibrant new look and a deeper ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.

This data feed is not available at this time.